Aditx Therapeutics’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Aditx researches, develops and commercializes immunosuppressants to enhance tolerance to transplanted organs. Read more

Amro Albanna's photo - President & CEO of Aditx Therapeutics

President & CEO

Amro Albanna

CEO Approval Rating

70/100

Founded:

2017

Status:

PublicNASDAQADTX

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Apple a competitor of Aditx Therapeutics?

Quarterly and Annual Revenue

Coming soon for Aditx Therapeutics!

Annual Revenue

Acquisitions

No recent acquisitions found related to Aditx Therapeutics

Aditx Therapeutics Funding History

$372.3K$11.4M

Since Aditx Therapeutics was founded in 2017, it has participated in 3 rounds of funding. In total Aditx Therapeutics has raised $11.4M. Aditx Therapeutics' last funding round was on Jun 2020 for a total of $11.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

IPO
Jun 2020
$11M
-
Equity
Nov 2018
$109.8K
-
Equity
Mar 2018
$262.5K
-

Total Funding: $11.4M

Since Aditx Therapeutics was founded in 2017, it has participated in 3 rounds of funding. In total Aditx Therapeutics has raised $11.4M. Aditx Therapeutics' last funding round was on Jun 2020 for a total of $11.0M

Investments

No recent investments found related to Aditx Therapeutics

Aditx Therapeutics News

September 3, 2020BioSpace

Aditxt Signs Collaboration Agreement with Salveo Diagnostics to Commercialize AditxtScore Platform Starting in Q4, 2020

Aditx Therapeutics, Inc. (Aditxt) (the "Company") (Nasdaq: ADTX), a life sciences company developing ... See more »
August 27, 2020FinanzNachrichten

Aditx Therapeutics to Present at The LD 500 Virtual Conference

Presentation on Thursday, September 3rd at 12:20 PM ET LOS ANGELES, CA / ACCESSWIRE / August 27, 2020... See more »
August 7, 2020RTTNews

ADiTx Therapeutics Surges 100% On COVID-19 Test

Shares of ADiTx Therapeutics, Inc. (ADTX) more than doubled on Thursday morning after the company lau... See more »
July 10, 2020MarketScreener

CEO, CIO, and Senior Advisors of Aditxt Complete Conversion of ~$1.1 Million in Accrued Compensation into Restricted IPO Units

(marketscreener.com) Loma Linda, CA, July 10, 2020 -- via NEWMEDIAWIRE -- Aditx Therapeutics, Inc. , ... See more »
July 6, 2020MarketScreener

Aditx Therapeutics, Inc. (Aditxt) Announces Closing of Initial Public Offering

(marketscreener.com) Trading on Nasdaq under Ticker "ADTX" This is a correction of the announcement. ... See more »
July 4, 2020Unique Finance

Aditx Therapeutics, Inc. (Aditxt) Announces Pricing of Initial Public Offering

Email Print Friendly Share Will Trade on the Nasdaq Capital Market Under Ticker "ADTX" Loma Linda, CA... See more »

Aditx Therapeutics Press Releases

August 25, 2020NewMediaWire

Head of R&D for the New Analyte Ventures at Abbott Diabetes Care, Namvar Kiaie Joins Aditx Therapeutics Board of Directors

Mr. Kiaie has Extensive Experience in Medical Device Product DevelopmentLoma Linda, CA - (NewMediaWir... See more »
August 6, 2020NewMediaWire

Aditxt Introduces AditxtScore for COVID-19 and Announces the Completion of Validation Studies by Stanford Blood Center

Company Plans to file for an Emergency Use Authorization (EUA) and 510(k) Application in the Current ... See more »
August 3, 2020NewMediaWire

Aditx Therapeutics Appoints Jeff Ramson, Wall Street Veteran and Founder of PCG Advisory as Senior Advisor, Capital Markets & Communications

LOMA LINDA, CA - (NewMediaWire) - August 03, 2020 - Aditx Therapeutics, Inc. (Aditxt) (the "Company")... See more »
July 23, 2020NewMediaWire

Aditxt to Present at Zooming with LD

Presentation on Tuesday, July 28th at 11:00 AM ETLoma Linda, CA - (NewMediaWire) - July 22, 2020 - Ad... See more »

Headquarters

11161 Anderson Street Suite 105-10014

Loma Linda, California92354

909-488-0844

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Aditx researches, develops and commercializes immunosuppressants to enhance tolerance to transplanted organs. Aditx Therapeutics was founded in 2017. Aditx Therapeutics' headquarters is located in Loma Linda, California, USA 92354. It has raised 11.4M...

CEO

Aditx Therapeutics's President & CEO, Amro Albanna, currently has an approval rating of 70%. Aditx Therapeutics's primary competitors are

Website

aditxt.com

Frequently Asked Questions about Aditx Therapeutics

  1. When was Aditx Therapeutics founded?

    Aditx Therapeutics was founded in 2017
  2. Who is Aditx Therapeutics's CEO?

    Aditx Therapeutics's CEO is Amro Albanna
  3. How much revenue does Aditx Therapeutics generate?

    Aditx Therapeutics generates $ < 1M in revenue
  4. How much funding does Aditx Therapeutics have?

    Aditx Therapeutics has historically raised $11.4M in funding
  1. Where is Aditx Therapeutics's headquarters?

    Aditx Therapeutics's headquarters is in Loma Linda California, USA
  2. How many employees does Aditx Therapeutics have?

    Aditx Therapeutics has 2 employees
  3. What sector does Aditx Therapeutics operate in?

    Aditx Therapeutics is in Pharmaceuticals